Racek, J., Rusnkov, H., Trefil, L
While research has restarted on a weekly islatravir pill at a lower dose combined with a six-monthly injection of lenacapavir, as well as trials of daily islatravir combined with other pills, development of a monthly pill and an annual implant has been shelved
The etiopathogenesis of FM is thought to involve complex interactions between genetic predisposition and environmental and biological factors, with central sensitization playing an important role [1, 5]
This syringe includes a passive needle retraction feature that eliminates the need to recap, reducing exposure and further lowering contamination risks
Researchers propose this mechanism could show selective toxicity toward cancer cells because: Tumor cells often lack catalase and other peroxide-neutralizing enzymes Cancer microenvironments contain elevated labile iron levels Normal cells maintain robust antioxidant defenses Clinical Trial Evidence Recent Phase II trials investigating vitamin C injections in cancer treatment have reported early signals that researchers describe as promising, though the evidence remains preliminary: Pancreatic Cancer Study: In a randomized Phase II trial of 34 patients with stage 4 metastatic pancreatic cancer led by Joseph Cullen at the University of IowaPharmacological ascorbate in combination with gemcitabine and nab-paclitaxel published in Redox Biology (2024)participants who received 75 grams (75,000 mg) of IV vitamin C three times weekly alongside standard chemotherapy reached a median overall survival of 16 months, compared with 8.3 months for chemotherapy alone
[Updated 2025 Oct 27]
